A real takeover target, page-11

r10,

The share price has no real bearing on what's been happening these last two years. The market is an ass! While the sp is much lower, cavatak has advanced heaps clinically.

As for going away and coming back 6 months, well now the sp is low maybe that's not such good advice imho. When it was $1.20 then yes. Buy low, sell high!

The lower the share price goes the more chance of a takeover offer.

I know a takeover has been mentioned for ages, and nothing has happened. But the same happened with Panbio. We expected a takeover, but it never happened. We waited and waited, and still nothing happened. But then one day it did.

cavatak makes such a massive difference to both BMS's and Merck's drugs, so it's just a matter of time.

And maybe the deal or takeover never comes, but I think it's likely personally.

cheers

ps. but feel free to come back in 6 months and write "I told you so"

;-)